WARNING: Today's post is going to rattle cages and put a spotlight on a potentially dark side of Internet marketing. Yeah, I'm probably going to tick some people off. That's life. I'm more concerned with speaking the truth. This is #2 in a series called The Truth About Internet Marketing. Part one was called "The Long Form Sales Letter. For some time it has been suspected that there is a "secret cabal" of Internet marketers... Continue Reading

In a landmark decision that will be sure to usher in a new world Internet order, a World Wide Web judge has just granted Internet marketing guru and entrepreneur Joel Comm the exclusive trademark rights to the ".com" web address suffix, placing all websites everywhere with a ".com" domain under the jurisdiction and discretion of Joel Comm. The decision came about when Joel Comm successfully sued Al Gore, who had previously laid claim to "inventing... Continue Reading

I received an 8 1/2" x 11" envelope today addressed to my business. Real official looking stuff. I open it up and it is a notice of estimated cash payment and claim form for a class action suit. Apparantly, my company is a member of the Class in the Visa Check/MasterMoney Antitrust Litigation. Don't ask me how I got in the class. I have no idea. The cash payment that I am entitled to as... Continue Reading

Look out folks, another anti-arthritis drug has been linked to cardiovascular problems. Pfizer says a new study found an increased risk of heart problems with the painkiller Celebrex. Last month, Vioxx was withdrawn from the market. You know what this means, doncha? Unleash the ambulence chasers! The sue-happy attorneys now have more red meat with which to deepen their pockets and chase the price of medical care and drugs higher and higher. Essentially, the study... Continue Reading

And so, the litigation hounds once again are unleashed on the prescription drug community. This time it is over Vioxx, an anti-arthitic drug manufactured by Merck. Research has long pointed to the fact that long-term use of Vioxx may contribute to heart attacks and strokes. Perhaps the FDA didn't study the drug long enough. Perhaps the pharmaceutical companies are only interested in money. Perhaps people don't read the warning labels. And perhaps some were willing... Continue Reading